Many symptoms associated with prostate cancer, like frequent urination or difficulty peeing, may be caused by less-serious concerns. Learn more.

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as demonstrated by the PRESTO, EMBARK, and ENZARAD trials. The PRESTO trial ...

The Gleason grading system for prostate cancer (PCa) is based on the proportions of Gleason patterns (GP) 3-5. While pure GP3 has minimal metastatic potential, it is unclear whether GP3 quantity in ...

Here’s a PSA about PSA—meaning a public service announcement about prostate specific antigen. Although checking the PSA levels in your blood is a routine way of screening for prostate cancer, just ...

Tamara Lotan, M.D., the Rose-Lee and Keith Reinhard Professor of Urologic Pathology, is the Brady’s new Director of Research. She is the first pathologist and the first woman to hold this position, ...

Radiotherapy benefits are most pronounced in patients with fewer than five bone metastases, improving progression-free survival and 5-year survival rates. Across all patients, radiotherapy ...

Xtandi addition to ADT and radiation did not significantly improve MFS in the overall high-risk prostate cancer population. Patients with clinical N1 disease showed improved five-year MFS with Xtandi, ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...

His Gleason score of 9 indicates it's one of the most aggressive cancer types The cancer has spread to his bones TUESDAY, Oct. 14, 2025 (HealthDay News) — Former President Joe Biden is now receiving ...